These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32259456)

  • 1. The potential and challenges of patient-derived organoids in guiding the multimodality treatment of upper gastrointestinal malignancies.
    Busslinger GA; Lissendorp F; Franken IA; van Hillegersberg R; Ruurda JP; Clevers H; de Maat MFG
    Open Biol; 2020 Apr; 10(4):190274. PubMed ID: 32259456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues.
    Gao M; Lin M; Rao M; Thompson H; Hirai K; Choi M; Georgakis GV; Sasson AR; Bucobo JC; Tzimas D; D'Souza LS; Buscaglia JM; Davis J; Shroyer KR; Li J; Powers S; Kim J
    Ann Surg Oncol; 2018 Sep; 25(9):2767-2775. PubMed ID: 30003451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold.
    Schmäche T; Fohgrub J; Klimova A; Laaber K; Drukewitz S; Merboth F; Hennig A; Seidlitz T; Herbst F; Baenke F; Ada AM; Groß T; Wenzel C; Ball CR; Praetorius C; Schmidt T; Ringelband-Schilling B; Koschny R; Stenzinger A; Roeder I; Jaeger D; Zeissig S; Welsch T; Aust D; Glimm H; Folprecht G; Weitz J; Haag GM; Stange DE
    Mol Cancer; 2024 Jan; 23(1):10. PubMed ID: 38200602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Single-Cell Technique to Increase Yield and Use of Gastrointestinal Cancer Organoids for Personalized Medicine Application.
    Gao M; Harper MM; Lin M; Qasem SA; Patel RA; Mardini SH; Gabr MM; Cavnar MJ; Pandalai PK; Kim J
    J Am Coll Surg; 2021 Apr; 232(4):504-514. PubMed ID: 33253861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-Derived Organoids from Locally Advanced Gastric Adenocarcinomas Can Predict Resistance to Neoadjuvant Chemotherapy.
    Yoon C; Lu J; Kim BJ; Cho SJ; Kim JH; Moy RH; Ryeom SW; Yoon SS
    J Gastrointest Surg; 2023 Apr; 27(4):666-676. PubMed ID: 36627466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of neoadjuvant chemotherapy and chemoradiotherapy on exercise capacity and outcome following upper gastrointestinal cancer surgery: an observational cohort study.
    West MA; Loughney L; Ambler G; Dimitrov BD; Kelly JJ; Mythen MG; Sturgess R; Calverley PM; Kendrick A; Grocott MP; Jack S
    BMC Cancer; 2016 Sep; 16(1):710. PubMed ID: 27589870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of Patient-Derived Gastric Cancer Organoid Model From Tissue Obtained by Endoscopic Biopsies.
    Song H; Park JY; Kim JH; Shin TS; Hong SA; Huda MN; Kim BJ; Kim JG
    J Korean Med Sci; 2022 Jul; 37(28):e220. PubMed ID: 35851862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal Cancer Patient Derived Organoids at the Frontier of Personalized Medicine and Drug Screening.
    Yang Z; Yu J; Wong CC
    Cells; 2024 Aug; 13(16):. PubMed ID: 39195202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-derived organoids as a platform for modeling a patient's response to chemoradiotherapy in esophageal cancer.
    Karakasheva TA; Gabre JT; Sachdeva UM; Cruz-Acuña R; Lin EW; DeMarshall M; Falk GW; Ginsberg GG; Yang Z; Kim MM; Diffenderfer ES; Pitarresi JR; Li J; Muir AB; Hamilton KE; Nakagawa H; Bass AJ; Rustgi AK
    Sci Rep; 2021 Oct; 11(1):21304. PubMed ID: 34716381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-derived organoids (PDOs) as a novel in vitro model for neuroblastoma tumours.
    Fusco P; Parisatto B; Rampazzo E; Persano L; Frasson C; Di Meglio A; Leslz A; Santoro L; Cafferata B; Zin A; Cimetta E; Basso G; Esposito MR; Tonini GP
    BMC Cancer; 2019 Oct; 19(1):970. PubMed ID: 31638925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicellular Modelling of Difficult-to-Treat Gastrointestinal Cancers: Current Possibilities and Challenges.
    Hakuno SK; Michiels E; Kuhlemaijer EB; Rooman I; Hawinkels LJAC; Slingerland M
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodality treatment of operable gastric and oesophageal adenocarcinoma: evaluating neoadjuvant, adjuvant and perioperative approaches.
    Davidson M; Chau I
    Expert Rev Anticancer Ther; 2018 Apr; 18(4):327-338. PubMed ID: 29431018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-derived organoids as individual patient models for chemoradiation response prediction in gastrointestinal malignancies.
    Le Compte M; Komen N; Joye I; Peeters M; Prenen H; Smits E; Deben C; de Maat M
    Crit Rev Oncol Hematol; 2021 Jan; 157():103190. PubMed ID: 33310278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Organoid-Based Preclinical Model of Human Gastric Cancer.
    Steele NG; Chakrabarti J; Wang J; Biesiada J; Holokai L; Chang J; Nowacki LM; Hawkins J; Mahe M; Sundaram N; Shroyer N; Medvedovic M; Helmrath M; Ahmad S; Zavros Y
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):161-184. PubMed ID: 30522949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esophagogastric junction and gastric adenocarcinoma: neoadjuvant and adjuvant therapy, and future directions.
    Sandler S
    Oncology (Williston Park); 2014 Jun; 28(6):505-12. PubMed ID: 25134325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resection.
    Cense HA; van Eijck CH; Tilanus HW
    Best Pract Res Clin Gastroenterol; 2006; 20(5):893-906. PubMed ID: 16997168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant therapy for gastrointestinal cancers.
    Kelsen D
    Oncology (Williston Park); 1993 Sep; 7(9):25-32; discussion 32, 35-6, 41. PubMed ID: 8217529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-derived Organoid Pharmacotyping is a Clinically Tractable Strategy for Precision Medicine in Pancreatic Cancer.
    Seppälä TT; Zimmerman JW; Sereni E; Plenker D; Suri R; Rozich N; Blair A; Thomas DL; Teinor J; Javed A; Patel H; Cameron JL; Burns WR; He J; Tuveson DA; Jaffee EM; Eshleman J; Szabolcs A; Ryan DP; Ting DT; Wolfgang CL; Burkhart RA
    Ann Surg; 2020 Sep; 272(3):427-435. PubMed ID: 32657929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organoid models of gastrointestinal cancers in basic and translational research.
    Lau HCH; Kranenburg O; Xiao H; Yu J
    Nat Rev Gastroenterol Hepatol; 2020 Apr; 17(4):203-222. PubMed ID: 32099092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-derived organoid models help define personalized management of gastrointestinal cancer.
    Aberle MR; Burkhart RA; Tiriac H; Olde Damink SWM; Dejong CHC; Tuveson DA; van Dam RM
    Br J Surg; 2018 Jan; 105(2):e48-e60. PubMed ID: 29341164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.